145 related articles for article (PubMed ID: 38185042)
1. Claudins and hepatocellular carcinoma.
Wang W; Zhou Y; Li W; Quan C; Li Y
Biomed Pharmacother; 2024 Feb; 171():116109. PubMed ID: 38185042
[TBL] [Abstract][Full Text] [Related]
2. Claudins and Gastric Cancer: An Overview.
Hashimoto I; Oshima T
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053454
[TBL] [Abstract][Full Text] [Related]
3. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells.
Suh Y; Yoon CH; Kim RK; Lim EJ; Oh YS; Hwang SG; An S; Yoon G; Gye MC; Yi JM; Kim MJ; Lee SJ
Oncogene; 2013 Oct; 32(41):4873-82. PubMed ID: 23160379
[TBL] [Abstract][Full Text] [Related]
4. Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma.
Zhou S; Piao X; Wang C; Wang R; Song Z
Mol Med Rep; 2019 Jul; 20(1):393-400. PubMed ID: 31115553
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
Front Genet; 2022; 13():783016. PubMed ID: 35281827
[No Abstract] [Full Text] [Related]
6. Claudin expression in breast cancer: high or low, what to expect?
Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma.
Sun L; Feng L; Cui J
Diagn Pathol; 2018 Sep; 13(1):72. PubMed ID: 30219077
[TBL] [Abstract][Full Text] [Related]
8. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
[TBL] [Abstract][Full Text] [Related]
9. Isolate-dependent use of claudins for cell entry by hepatitis C virus.
Haid S; Grethe C; Dill MT; Heim M; Kaderali L; Pietschmann T
Hepatology; 2014 Jan; 59(1):24-34. PubMed ID: 23775920
[TBL] [Abstract][Full Text] [Related]
10. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.
Zheng A; Yuan F; Li Y; Zhu F; Hou P; Li J; Song X; Ding M; Deng H
J Virol; 2007 Nov; 81(22):12465-71. PubMed ID: 17804490
[TBL] [Abstract][Full Text] [Related]
11. Identification of claudin-2, -6, -11 and -14 as prognostic markers in human breast carcinoma.
Jia H; Chai X; Li S; Wu D; Fan Z
Int J Clin Exp Pathol; 2019; 12(6):2195-2204. PubMed ID: 31934042
[TBL] [Abstract][Full Text] [Related]
12. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
[TBL] [Abstract][Full Text] [Related]
13. Double mutation of claudin-1 and claudin-3 causes alopecia in infant mice.
Suzuki K; Yamaga K; Tokumasu R; Katsuno T; Tanaka H; Chiba S; Yagi T; Katayama I; Tamura A; Murota H; Tsukita S
Ann N Y Acad Sci; 2023 May; 1523(1):51-61. PubMed ID: 37002535
[TBL] [Abstract][Full Text] [Related]
14. The mRNA of claudins is expressed in the endolymphatic sac epithelia.
Matsubara A; Miyashita T; Mori T; Akiyama K; Inamoto R; Mori N
Auris Nasus Larynx; 2012 Aug; 39(4):361-4. PubMed ID: 21871748
[TBL] [Abstract][Full Text] [Related]
15. Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis.
Arabzadeh A; Troy TC; Turksen K
BMC Cancer; 2007 Oct; 7():196. PubMed ID: 17945025
[TBL] [Abstract][Full Text] [Related]
16. The Expression of the Claudin Family of Proteins in Colorectal Cancer.
Cox KE; Liu S; Hoffman RM; Batra SK; Dhawan P; Bouvet M
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540693
[TBL] [Abstract][Full Text] [Related]
17. Claudins and pathogenesis of viral infection.
Tawar RG; Colpitts CC; Lupberger J; El-Saghire H; Zeisel MB; Baumert TF
Semin Cell Dev Biol; 2015 Jun; 42():39-46. PubMed ID: 25960372
[TBL] [Abstract][Full Text] [Related]
18. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
Uthayanan L; El-Bahrawy M
J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
[TBL] [Abstract][Full Text] [Related]
19. Polar and charged extracellular residues conserved among barrier-forming claudins contribute to tight junction strand formation.
Piontek A; Rossa J; Protze J; Wolburg H; Hempel C; Günzel D; Krause G; Piontek J
Ann N Y Acad Sci; 2017 Jun; 1397(1):143-156. PubMed ID: 28415153
[TBL] [Abstract][Full Text] [Related]
20. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]